Combination chemotherapy with mitomycin C and methotrexate is active against metastatic HER2-negative breast cancer even after treatment with anthracycline, taxane, capecitabine, and vinorelbine
Crossref DOI link: https://doi.org/10.1186/s40064-015-1159-4
Published Online: 2015-07-26
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Fukuda, Takayo
Tanabe, Masahiko
Kobayashi, Kokoro
Fukada, Ippei
Takahashi, Shunji
Iwase, Takuji
Ito, Yoshinori
License valid from 2015-07-26